Ezekowitz Alan — SEC Form 4 filings
SEC reporting owner CIK 1780209. 11 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-06-11 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 2 filings — 100,000 shares, $608,204 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 18,000 shares, $65,614 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: purchase of 41,355 shares @ $6.00 ($248,130) in Septerna, Inc., filed 2025-03-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Septerna, Inc. (SEPN) | Director | 4 | 4 legs · 100,000 sh · $608,204 | — | 2 |
| Fulcrum Therapeutics, Inc. (FULC) | Director | 4 | — | 1 leg · 18,000 sh · $65,614 | 3 |
| Organon & Co. (OGN) | Director | 3 | — | — | 3 |
Form 4 filings — Ezekowitz Alan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Fulcrum Therapeutics, Inc. (FULC) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Fulcrum Therapeutics, Inc. (FULC) | Sale (S): 18,000 @ $3.65 | EDGAR |
| 2026-06-30 | 4 | Septerna, Inc. (SEPN) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Organon & Co. (OGN) | Grant/award (A): 17,857.14 (derivative) @ $13.44 | EDGAR |
| 2025-06-30 | 4 | Fulcrum Therapeutics, Inc. (FULC) | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Septerna, Inc. (SEPN) | Grant/award (A): 16,623 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Organon & Co. (OGN) | Grant/award (A): 23,904.38 (derivative) @ $10.04 | EDGAR |
| 2025-03-10 | 4 | Septerna, Inc. (SEPN) | Purchase (P): 13,319 @ $6.93 | EDGAR |
| 2025-03-06 | 4 | Septerna, Inc. (SEPN) | Purchase (P): 7,491 @ $6.35 · Purchase (P): 37,835 @ $5.82 · Purchase (P): 41,355 @ $6 | EDGAR |
| 2024-06-18 | 4 | Fulcrum Therapeutics, Inc. (FULC) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Organon & Co. (OGN) | Grant/award (A): 9,638.55 (derivative) @ $20.75 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1780209 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →